Almost four years ago, I had my second dexa scan and got the news that I have learned is typical: in the five years after menopause, my bone density went from normal to osteopenia. I lost 13% of my bone density in my spine. I got a weirdly chipper note…
Read more
REDWOOD CITY, CA (July 2, 2024) – Bone Health Technologies (BHT), a leading medtech innovator developing breakthrough noninvasive and drug-free solutions for low bone density, today announced the company has been awarded a fifth patent for Osteoboost—the first and only FDA-cleared prescription medical device to treat osteopenia. The patent, US…
Read more
Redwood City, CA – January 18, 2024 – Bone Health Technologies today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for OsteoboostTM, the first non-pharmacological device-based prescription treatment for postmenopausal women diagnosed with osteopenia (low bone density). Osteoboost is a wearable belt device, worn on the…
Read more
First Device to Demonstrate Bone Strength Benefit in Clinical Trial REDWOOD CITY, CA (DEC, 2023)– Bone Health Technologies (BHT), a leading innovator in health technologies to improve bone health, has been granted its fourth patent to further its commercialization of the Osteoboost device. Osteoboost has been shown in clinical trials…
Read more
Osteoboost Reduced the Loss of Vertebral Bone Strength by 83% in One Year for Per Protocol Participants Vancouver, BC, Canada (October 13, 2023)– Bone Health Technologies (BHT), a leading innovator in health technologies to improve bone health, is presenting top-line results from its pivotal trial for the Osteoboost at ASBMR…
Read more
Redwood City, CA (SEPTEMBER 20TH, 2023) – Bone Health Technologies (BHT), a leader in developing technologies for improving bone health and preventing bone diseases, announces the appointment of two new board directors: Jeani Delagardelle and Eric Meyer. Onboarding these two expert thought leaders will aid in progressing BHT’s development, research,…
Read more
Per Protocol Participants saw an 85% Reduction in the Loss of Vertebral Bone Density in One Year Chicago, IL (June 16, 2023)– Bone Health Technologies (BHT), a pioneer in health technologies for preventing and treating bone health diseases, is presenting pivotal trial data for Osteoboost, a novel treatment for low…
Read more
